Taphalgin Shows Efficacy in Phase II Study for Postoperative Pain

01.09.2021

Our commitment to advancing pain relief is affirmed with the successful wrap-up of a Phase II open-label, comparative, multicenter, randomized clinical study. The focus of the study was the efficacy and safety of Taphalgin solution for subcutaneous injections in patients experiencing pain in the early postoperative period. The results further bolster our confidence in Taphalgin's potential in the market.

Taphalgin Shows Efficacy in Phase II Study for Postoperative Pain

About

Recent news

Taphalgin Completes Another Successful Phase III Clinical Study for Postoperative Pain

Phase III Study Validates Taphalgin‘s Efficacy for Cancer Pain Management

Сontacts

©2016-2023 PVP LABS PTE. LTD